Education
About Us
Working with TipRanks
Follow Us
Cibus (CBUS)
NASDAQ:CBUS
CBUS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.38 - $10.76
Previous CloseN/A
Volume64.89K
Average Volume (3M)491.61K
Market Cap
$86.17M
Enterprise Value$88.02M
Total Cash (Recent Filing)$23.59M
Total Debt (Recent Filing)$35.65M
Price to Earnings (P/E)―
Beta2.95
Next Earnings
Aug 07, 2025EPS Estimate
-0.6Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.34
Shares Outstanding48,386,467
10 Day Avg. Volume241,383
30 Day Avg. Volume491,607
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.77
Price to Sales (P/S)0.00
P/FCF Ratio-0.91
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue5.46
Enterprise Value/Gross Profit29.17
Enterprise Value/Ebitda-0.07
Forecast
1Y Price Target
$21.17Price Target Upside1130.81% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Cibus News
PremiumCompany Announcements
Cibus Announces Public Offering of Common Stock
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe recent endorsement by EU member states on the regulation of plants obtained by New Genomic Techniques could eventually translate into an expanded market opportunity for Cibus in Europe.
Regulatory ApprovalsThe US FDA completed its Plant Biotechnology Consultation Program for the company’s altered lignin alfalfa trait for livestock feed, enabling the commercialization of the plant.
Revenue GrowthCibus' revenues increased by 135% year-over-year, mainly through collaboration agreements and sales related to developing a palm oil alternative.
Bears Say
Cash Flow ConcernsA serendipitous opportunity in the form of sustainable ingredients, specifically fermentation based biofragrance products, could somewhat mitigate the company’s need for cash.
Financial PerformanceThe company produced a net loss of ~$47M, widening over 300% y/y, primarily due to a significant goodwill impairment charge.
Options Prices
Currently, No data available
---
Ownership Overview
35.46% Insiders
7.58% Mutual Funds
7.21% Other Institutional Investors
47.66% Public Companies and
Individual Investors
CBUS FAQ
What was Cibus’s price range in the past 12 months?
Cibus lowest stock price was $1.38 and its highest was $10.76 in the past 12 months.
What is Cibus’s market cap?
Cibus’s market cap is $86.17M.
When is Cibus’s upcoming earnings report date?
Cibus’s upcoming earnings report date is Aug 07, 2025 which is in 15 days.
How were Cibus’s earnings last quarter?
Cibus released its earnings results on May 08, 2025. The company reported -$1.34 earnings per share for the quarter, missing the consensus estimate of -$0.583 by -$0.757.
Is Cibus overvalued?
According to Wall Street analysts Cibus’s price is currently Undervalued.
Does Cibus pay dividends?
Cibus does not currently pay dividends.
What is Cibus’s EPS estimate?
Cibus’s EPS estimate is -0.6.
How many shares outstanding does Cibus have?
Cibus has 48,386,467 shares outstanding.
What happened to Cibus’s price movement after its last earnings report?
Cibus reported an EPS of -$1.34 in its last earnings report, missing expectations of -$0.583. Following the earnings report the stock price went down -8.936%.
Which hedge fund is a major shareholder of Cibus?
Currently, no hedge funds are holding shares in CBUS
Cibus Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$21.17 (1130.81% Upside)
$21.17 (1130.81% Upside)
Blogger Sentiment
Bullish
CBUS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 7.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $500.0 over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 13.5%
Last 30 Days ▲ 13.5%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-81.97%
12-Months-Change
Fundamentals
Return on Equity
-157.73%
Trailing 12-Months
Asset Growth
-37.14%
Trailing 12-Months
Company Description
Cibus
Cibus (CBUS) is an agricultural biotechnology company focused on developing and commercializing precision gene editing technologies for the agricultural sector. The company specializes in creating advanced plant traits that improve crop performance, enhance disease resistance, and increase yields, thereby supporting sustainable agriculture practices. Cibus operates at the intersection of biotechnology and agriculture, offering innovative solutions that address the growing global demand for food security and sustainable farming.
CBUS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in regulatory milestones and commercial strategy validation, particularly in gene editing and sustainable ingredients. However, financial results showed increased net loss and SG&A expenses, raising concerns about cash burn and profitability.Read More>CBUS Stock 12 Month Forecast
Average Price Target
$21.17
▲(1130.81%Upside)